Johnson & Johnson to acquire V-Wave Ltd. in $1.1bn deal to enhance heart failure treatment
Johnson & Johnson (NYSE: JNJ) has made headlines with its decision to acquire V-Wave Ltd., a private company renowned for its cutting-edge treatments for heart failure. The agreement, valued at an upfront payment of $600 million and potential additional payments totaling approximately $1.1 billion, marks a strategic expansion for Johnson & Johnson MedTech. This acquisition […]